Skip to content

Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France

Evaluation of Vitamin D Deficiency Distribution in Children With Sickle Cell Disease Followed in Lyon, France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04694976
Acronym
EVADDREP
Enrollment
130
Registered
2021-01-05
Start date
2021-02-04
Completion date
2022-02-03
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease, Vitamin D Deficiency

Keywords

Vitamin D deficiency prevalence rate, Vitamin D level, Children with sickle cell disease

Brief summary

Vitamin D deficiency may be under-diagnosed in sickle cell disease French children. Therefore, the investigator need an epidemiologic study about the prevalence of vitamin D deficiency in this specific population. There are not specific guidelines neither testing nor treatment. The investigator propose to test vitamin D status in all children with sickle cell disease who are consulting their referring haematologist doctor or in the emergency ward.

Interventions

BIOLOGICAL25-OH Vitamin D measure

As a complement to the off-study prescription, the investigator are taking two 1 mL tubes of extra blood to measure vitamin D, calcium, phosphorus, parathyroid hormone (PTH) and creatinine.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children: under 18 years old * Sickle cell any genetic type homozygous or composite heterozygous * To receive an assessment independently of the study, during a presentation to the emergency ward and/or a follow-up consultation by the hematologist * no parental opposition signed by at least one parent/legal representative and no child opposition * social security beneficiary

Exclusion criteria

* History of hematologic grafting

Design outcomes

Primary

MeasureTime frameDescription
Determination of 25-OH Vitamin D levelDay 1We classify vitamin D status as follows : * Sufficiency \> \>75nmol/L (\>30 ng/mL) * Insufficiency 50-75 nmol/L (20-30 ng/mL) * Deficiency 12-50nmol/L (5-20 ng/mL) * Severe deficiency \<12 nmol/L (\<5 ng/mL)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026